Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 5 February 2008
Vol. 1, Issue 5, p. ec51
[DOI: 10.1126/stke.15ec51]

EDITORS' CHOICE

Immunology Interfering with Inflammation

Stephen J. Simpson

Science, AAAS, Cambridge CB2 1LQ, UK

The efficient and selective targeting of small interfering RNA (siRNA) molecules to cells could help to harness this technology for treating disease. Peer et al. (see the Perspective by Szoka) combine nanoscale liposomal packaging of siRNAs with antibody targeting to immune cells. The targeted siRNA cargo was able to find and efficiently inactivate its target, a key cell-cycle regulating molecule called cyclin D1. Furthermore, the systemic injection of the packaged siRNA particles reversed pathology in a mouse model of inflammatory bowel disease.

D. Peer, E. J. Park, Y. Morishita, C. V. Carman, M. Shimaoka, Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science 319, 627-630 (2008). [Abstract] [Full Text]

F. Szoka, The art of assembly. Science 319, 578-579 (2008). [Summary] [Full Text]

Citation: S. J. Simpson, Interfering with Inflammation. Sci. Signal. 1, ec51 (2008).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882